Topiox Research Centre is a young, emerging, dynamic R&D facility engaged in the development, optimization, scale up and tech transfer of generic and 505(b)2 products for ophthalmic, dermal, otic and nasal route of administration that are targeted to be marketed globally. With our expertise in valued transformation of product from Ideation to market, we aim to serve speciality pharma companies globally. Our endeavour is to help our customers accelerate in building a healthy future and successful portfolio of products.